The use of inosine pranobex is associated with a lower risk for mortality in patients with COVID, a new study suggests.
A prior COVID infection could make you more susceptible to heart attack, stroke or death, according to a new study from Cleveland Clinic and the University of Southern California. The risk of a major ...
No evidence was observed among adult and pediatric patients across 3 large cohorts to suggest reduced risk for long COVID over time, indicating long COVID remains an ongoing public health concern.
The IDSA released 2025 guidelines for treating mild to moderate COVID-19, emphasizing risk-based antiviral use to prevent ...
On Nov. 12, the Journal reported that Presbyterian and UNM Hospitals had activated the state's crisis standards of care plan, which, among other things, establishes a legal mechanism for allocating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results